|30.49||+0.77 / +2.59%|
As of 4:02pm ET
|30.50||+0.0061 / +0.02%|
The 3 analysts offering 12-month price forecasts for Emergent BioSolutions Inc have a median target of 40.00, with a high estimate of 45.00 and a low estimate of 38.00. The median estimate represents a +31.19% increase from the last price of 30.49.
The current consensus among 3 polled investment analysts is to Buy stock in Emergent BioSolutions Inc. This rating has held steady since October, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.